Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew A Windsor

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Biochemistry|June 17, 2009
Peptide inhibitors identify roles for SSB C-terminal residues in SSB/exonuclease I complex formationDuo Lu, Matthew A Windsor, Samuel H Gellman, et al.
Angewandte Chemie (International Ed. in English)|March 12, 2008
Sequence-based design of alpha/beta-peptide foldamers that mimic BH3 domainsW Seth Horne, Melissa D Boersma, Matthew A Windsor, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2013
Exploring the molecular determinants of substrate-selective inhibition of cyclooxygenase-2 by lumiracoxibMatthew A Windsor, Pieter L Valk, Shu Xu, et al.
Angewandte Chemie (International Ed. in English)|December 19, 2008
A rationally designed aldolase foldamerManuel M Müller, Matthew A Windsor, William C Pomerantz, et al.
American Journal of Ophthalmology|December 12, 2017
Estimating Public and Patient Savings From Basic Research-A Study of Optical Coherence Tomography in Managing Antiangiogenic TherapyMatthew A Windsor, Sissi J J Sun, Kevin D Frick, et al.
American Journal of Ophthalmology|April 16, 2018
Estimating Medicare and Patient Savings From the Use of Bevacizumab for the Treatment of Exudative Age-related Macular DegenerationPhilip J Rosenfeld, Matthew A Windsor, William J Feuer, et al.
ACS Medicinal Chemistry Letters|September 18, 2012
Substrate-Selective Inhibition of Cyclooxygenase-2: Development and Evaluation of Achiral Profen ProbesMatthew A Windsor, Daniel J Hermanson, Philip J Kingsley, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Biochemistry|June 17, 2009
Peptide inhibitors identify roles for SSB C-terminal residues in SSB/exonuclease I complex formationDuo Lu, Matthew A Windsor, Samuel H Gellman, et al.
Angewandte Chemie (International Ed. in English)|March 12, 2008
Sequence-based design of alpha/beta-peptide foldamers that mimic BH3 domainsW Seth Horne, Melissa D Boersma, Matthew A Windsor, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2013
Exploring the molecular determinants of substrate-selective inhibition of cyclooxygenase-2 by lumiracoxibMatthew A Windsor, Pieter L Valk, Shu Xu, et al.
Angewandte Chemie (International Ed. in English)|December 19, 2008
A rationally designed aldolase foldamerManuel M Müller, Matthew A Windsor, William C Pomerantz, et al.
American Journal of Ophthalmology|December 12, 2017
Estimating Public and Patient Savings From Basic Research-A Study of Optical Coherence Tomography in Managing Antiangiogenic TherapyMatthew A Windsor, Sissi J J Sun, Kevin D Frick, et al.
American Journal of Ophthalmology|April 16, 2018
Estimating Medicare and Patient Savings From the Use of Bevacizumab for the Treatment of Exudative Age-related Macular DegenerationPhilip J Rosenfeld, Matthew A Windsor, William J Feuer, et al.
ACS Medicinal Chemistry Letters|September 18, 2012
Substrate-Selective Inhibition of Cyclooxygenase-2: Development and Evaluation of Achiral Profen ProbesMatthew A Windsor, Daniel J Hermanson, Philip J Kingsley, et al.
Pageof 1